Prostate cancer: diagnosis and management

National Institute for Health and Care Excellence

This Guidelines summary provides the recommendations that are relevant to primary care. Please refer to the full guideline for the complete list of recommendations

Low-risk localised prostate cancer

Active surveillance

  • Offer active surveillance as an option to men with low-risk localised prostate cancer for whom radical prostatectomy or radical radiotherapy is suitable
  • Consider using the protocol below for men who have chosen active surveillance:
    • Year 1 of active surveillance; every 3–4 months, measure prostate-specific antigen (PSA)
    • Years 2–4 of active surveillance; every 3–6 months, measure PSA
    • Year 5 and every year thereafter until active surveillance ends: every 6 months, measure PSA

Register to view this page

Log in or register now for FREE in order to:

  • benefit from unlimited access to all pages, including:
    • 180+ guideline summaries
    • 1000+ evidence-based articles
  • review and leave comments on all articles and summaries
  • automatically track your reading and learning via your CPD tracker
  • on-demand webinars presented by leading clinical experts

Registration only takes 2 minutes and it will give you FREE access to all content across:



Log in

Need help? Email us